How much does Ensacove (Ensartinib Hydrochloride Capsules) Cost& price without insurance in China?
Ensacove® is the commercial brand name of Ensartinib Hydrochloride Capsules, an orally active second-generation anaplastic lymphoma kinase (ALK) inhibitor developed by Betta Pharmaceuticals. It selectively inhibits ALK tyrosine kinase activity, blocking downstream signaling pathways to suppress the proliferation and survival of ALK-positive tumor cells.
Main Indications
Treatment of anaplastic lymphoma kinase (ALK)-positive locally advanced or metastatic non-small cell lung cancer (NSCLC) in adult patients.
Common Side Effects
Common mild adverse reactions: Nausea, vomiting, diarrhea, fatigue, rash, and elevated transaminases.
Laboratory abnormalities: Decreased white blood cell count, neutropenia, and increased creatinine.
Severe but uncommon risks: Severe hepatotoxicity, interstitial lung disease/pneumonitis, and QT interval prolongation.
Approval Status in China
Ensacove® (Ensartinib Hydrochloride Capsules, 100mg) was officially approved for marketing in China in 2020. It is currently a prescription anti-tumor drug included in China’s National Medical Insurance List.
Buy Ensacove (Ensartinib Hydrochloride Capsules) online from China and save up to 80% on costs . no insurance needed . compare prices from a certified HongKong pharmacy .with fast shipping. Contact us now on WhatsApp to get the latest prices.
